ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 113,75
-1,00%
Dow Jones
39 806,77
-0,49%
DAX
18 688,14
-0,42%
Brent Oil
82,375
-1,38%
Bitcoin
71 277,86
-0,24%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Tetra Bio Pharma Inc (TBP)

  7. Tetra Bio Pharma Inc (TBP) Actualités

TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:TBP
DateHeureSourceTitreSymboleSociété
07/03/202314h01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
07/03/202313h59PR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
11/02/202300h27PR Newswire (Canada)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
22/12/202213h41PR Newswire (Canada)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
06/12/202213h00PR Newswire (US)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
29/11/202213h00PR Newswire (US)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
18/11/202218h23PR Newswire (Canada)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
27/10/202219h57PR Newswire (US)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
11/10/202213h42PR Newswire (US)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
08/09/202213h44PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
06/09/202215h28PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSX:TBPTetra Bio Pharma Inc
06/09/202215h27PR Newswire (Canada)IIROC Trade Resumption - TBPTSX:TBPTetra Bio Pharma Inc
06/09/202215h13PR Newswire (Canada)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
12/08/202204h19PR Newswire (US)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
10/08/202212h30PR Newswire (Canada)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
12/07/202213h30PR Newswire (Canada)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
06/06/202213h33PR Newswire (Canada)Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory UpdateTSX:TBPTetra Bio Pharma Inc
31/05/202216h38PR Newswire (Canada)Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special MeetingTSX:TBPTetra Bio Pharma Inc
30/05/202213h44PR Newswire (Canada)Tetra Bio-Pharma Appoints Chief Financial OfficerTSX:TBPTetra Bio Pharma Inc
18/05/202213h56PR Newswire (US)Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBDTSX:TBPTetra Bio Pharma Inc
17/05/202217h14PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of First Tranche with CannvalateTSX:TBPTetra Bio Pharma Inc
10/05/202213h00PR Newswire (US)Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD TechnologyTSX:TBPTetra Bio Pharma Inc
05/05/202212h30PR Newswire (US)Tetra Bio-Pharma and Cannvalate Enter Into PartnershipTSX:TBPTetra Bio Pharma Inc
17/03/202211h30PR Newswire (Canada)Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDATSX:TBPTetra Bio Pharma Inc
08/03/202212h30PR Newswire (US)Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBDTSX:TBPTetra Bio Pharma Inc
01/03/202201h49PR Newswire (Canada)Tetra Bio-Pharma Provides Management UpdateTSX:TBPTetra Bio Pharma Inc
22/02/202212h30PR Newswire (US)Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary SupplementTSX:TBPTetra Bio Pharma Inc
16/02/202212h30PR Newswire (Canada)Tetra Bio-Pharma Receives $4.5M from the Ministère de l'Économie et de l'Innovation/Investissement QuébecTSX:TBPTetra Bio Pharma Inc
14/02/202213h00PR Newswire (US)Tetra Bio-Pharma Enters into a Strategic Partnership with AvicannaTSX:TBPTetra Bio Pharma Inc
21/12/202115h24PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of UnitsTSX:TBPTetra Bio Pharma Inc
 Showing the most relevant articles for your search:TSX:TBP

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
EU
CAP
Capgemini
NYSE
JPM
JP Morgan Chase
EU
ACA
Credit Agricole
EU
SGO
Cie de SaintGobain
EU
ORA
Orange
SPI
SP500
S&P 500
EU
HO
Thales
EU
BNP
BNP Paribas
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés